The CSN 2022 Webinar Series are supported by an unrestricted educational grant from Glaxo Smith Kline.

Challenges & Strategies to Improve BP Measurement During COVID-Era


Its imperative to maintain healthy blood pressure levels at all times. It becomes but even more important in the era of COVID-19 as it might increase the risk of experiencing severe complications from the virus. Hypertension Canada, in collaboration with the Canadian Society of Nephrology, is proud to present a webinar on the challenges of blood pressure measurement during COVID-19 and look at ways to improve it.

Learning Objectives

In this webinar, the presenters will discuss:

  • The importance of out-of-office diagnosis/monitoring of hypertension, especially in the COVID-era
  • Office vs home BP measurement
  • Correct BP technique for each measurement method
  • Hypertension Canada’s BP Device Recommendations Program
  • The utilization of 24-hour ambulatory BP monitoring (ABPM) for diagnosis and management of HTN in Canada
  • The relevance of 24-hour ABPM for diagnosis and management of White-coat HTN, Masked HTN, and impaired Nocturnal Patterns of BP
  • BP targets for CKD and non-CKD hypertensive patients based on measurement method

Section 2 – Self Learning Credits
For information on how this activity fits in the Royal College Maintenance of Certification (MOC) Program, please visit the Royal College’s website ( For more personalized support, please contact the Royal College Services Centre(1-800-461-9598) or your local CPD Educator.


Laura Kuyper, MD

Dr. Laura Kuyper completed her fellowship in General Internal Medicine at the University of British Columbia in 2013. She is an American Society of Hypertension Clinical Hypertension Specialist and is the Director of the Vancouver General Hospital Hypertension Clinic in Vancouver BC. She is also a guideline author on the Hypertension Canada Guidelines on Resistant Hypertension.

Marcel Ruzicka, MD, PhD

Dr. Marcel Ruzicka is associate professor of medicine in the Division of Nephrology at the University of Ottawa. He is nephrologist and hypertension specialist. He is the medical director of the Hypertension Program at the Ottawa Hospital certified as Comprehensive Hypertension Centre by the American Heart Association/Council on High Blood Pressure. As a researcher he authorized over 100 papers in hypertension and kidney disease. He is a long-standing chair of the Hypertension Guidelines Committee on Renal, Renovascular, and Resistant Hypertension and co-author of the Guidelines on the Detection, Diagnosis, and Management of Hypertension in Canada.

Nadia Khan, MD

Dr. Nadia Khan is a Professor and Head of General Internal Medicine at the University of British Columbia, scientist at the Center for Health Evaluation and Outcomes Sciences and an American Society of Hypertension Clinical Specialist in hypertension. Dr. Khan published over 100 papers on hypertension epidemiology and ethnic differences in cardiovascular disease and risk factors. Dr. Khan is a Hypertension Canada guideline author and was past President of Hypertension Canada from 2016-2020. She is the lead for Research and Education at the International Society of Hypertension.

This program is being supported by an educational grant from AstraZeneca